iShares S&P Global Healthcare Sect.(ETF) (AMEX:IXJ)

texasfight08 (< 20) Submitted: 5/23/2009 2:18:39 AM : Start Price: $39.06 IXJ Score: +2.92

This ETF has badly underperformed the S&P YTD and will likely do so for quite some time. Investors are not recognizing / paying for the extensive R&D CAPEX of these companies. Additionally, many of these companies are rolling off patents and will be punished by generic competitors. I don't expect pharmas to payoff until a solid bull market is underway.

tthwebster (26.38) Submitted: 3/30/2009 10:38:47 PM : Start Price: $36.97 IXJ Score: -11.20

Betting to outperform the 500 this leg down.

GKuhfeldt (45.03) Submitted: 1/20/2009 1:43:13 PM : Start Price: $40.01 IXJ Score: -19.11

The tail end of the Baby Boomers will be reaching retirement in the next 10-15 years. That combined with the low price as a result of this economy means over the long term this ETF can only go up. People will always need health care. Additionally, this is a GLOBAL Healthcare ETF. That gives it a more diverse base to provide for a more defensive long position.

jaschajabes (87.39) Submitted: 6/20/2007 9:42:41 AM : Start Price: $55.52 IXJ Score: +12.63

life expectancy rises so costs do as well. I see profits for the long haul here.